Alnylam Pharmaceuticals Inc

-0.21 (-0.15%)
Products, Strategic Combinations

Alnylam Announces Collaboration With Novartis To Explore Targeted Therapy To Restore Liver Function

Published: 01/06/2022 12:57 GMT
Alnylam Pharmaceuticals Inc (ALNY) - Alnylam Announces Collaboration With Novartis to Explore Targeted Therapy to Restore Liver Function.
Alnylam - Collaboration Aims to Develop Liver-targeted Therapy As a Potential Alternative to Transplantation for Patients Experiencing Liver Failure.
Alnylam Pharmaceuticals - Agreement Will Bring Alnylam's Proprietary Sirna Technology to Bear on Liver Target Identified by Novartis Researchers.
Alnylam Pharmaceuticals Inc - Alnylam Will Develop and Test Potential Sirnas Using Target-specific Assays Developed by Novartis.
Alnylam Pharmaceuticals Inc - Once a Lead Candidate is Identified, Further Development and Clinical Research Will Be Conducted by Novartis.